Deutsche Bank Ag\ Finch Therapeutics Group, Inc. Transaction History

Deutsche Bank Ag\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.91 - $5.11 $7,840 - $20,976	-4,105 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$5.02 - $10.47 $2,399 - $5,004	-478 Reduced 10.43%	4,105 $21,000
Q4 2021 Feb 11, 2022	BUY	$8.95 - $16.88 $2,076 - $3,916	232 Added 5.33%	4,583 $46,000
Q3 2021 Nov 04, 2021	SELL	$12.2 - $16.75 $1,720 - $2,361	-141 Reduced 3.14%	4,351 $57,000
Q2 2021 Aug 11, 2021	BUY	$12.03 - $17.51 $54,038 - $78,654	4,492 New	4,492 $63,000

Ticker FNCH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,688,400
Market Cap $63.4M
Description
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.